The Protease of Human T-Cell Leukemia Virus Type-1 is a Potential Therapeutic Target

E-ISSN： 1873-4286|13|12|1285-1294

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.12, 2007-04, pp. : 1285-1294

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Roles of miRNAs in virus-mediated cellular transformation: lessons from human T-cell leukemia virus type 1

By Yeung Man Lung Jeang Kuan-Teh

Future Virology, Vol. 6, Iss. 11, 2011-11 ,pp. : 1351-1360

Future Medicine

Access to resources Recommend Favorite

New insights into the pathogenesis, diagnosis and treatment of human T-cell leukemia virus type 1-induced disease

By Pandya Devanshi Rahman Saifur Wigdahl Brian Khan Zafar K Jain Pooja

Future Virology, Vol. 2, Iss. 5, 2007-09 ,pp. : 481-493

Future Medicine

Access to resources Recommend Favorite

Is there a role for ubiquitin or SUMO in human T-cell leukemia virus type 2 Tax-induced NF-&kgr;B activation?

By Lavorgna Alfonso Harhaj Edward W

Future Virology, Vol. 8, Iss. 3, 2013-03 ,pp. : 223-227

Future Medicine

Access to resources Recommend Favorite

Are B Cells a Potential Target for Therapeutic Intervention in the Classical T Cell-Mediated Autoimmune Disease Type 1 Diabetes?

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 8, Iss. 2, 2009-06 ,pp. : 130-138

Bentham Science Publishers

Access to resources Recommend Favorite

Protein Kinase C-&thgr; (PKC&thgr;), a Potential Drug Target for Therapeutic Intervention with Human T Cell Leukemias

Current Cancer Drug Targets, Vol. 2, Iss. 2, 2002-06 ,pp. : 125-134

Bentham Science Publishers

Access to resources Recommend Favorite